California's Versartis is having quite a year, pulling down another $20 million in venture financing to get its once-a-month growth hormone through mid-stage trials.
Stockholm-based Pharmalink AB is banking $15 million from a C round designed to get one drug through a Phase IIb study and position another therapy for a pivotal trial of its own.
Three months after in-licensing a preclinical cancer drug from Array BioPharma ($ARRY), the upstart biotech Loxo Oncology announced that it has a $33 million Series A lined up to fund the work ahead.
When Johnson & Johnson does an R&D event, they often like to make a flourish--walking the walk as they talk the talk. That high-impact style was on full display in London today as the pharma giant spearheaded a $42 million venture investment in an up-and-coming antibody developer, inked one collaboration pact on immune-mediated diseases and a second vaccine research partnership that will connect with a pair of biotechs and a research institute.
Amid renewed optimism in biotech venture capital, Seattle stalwart Frazier Healthcare has pulled down a $377 million fund, surpassing its goal as it scouts for the next wave of emerging drug developers.
Cydan, an orphan-drug accelerator bankrolled by New Enterprise Associates and Pfizer Ventures, has secured another $10 million in venture cash.
Lexington, MA's Inotek has pulled down a $21 million round to advance its lead product, designed to ease in-eye pressure for glaucoma patients.
Looking at this year's boom in high-dollar biotech IPOs, you can't miss the fingerprints of Third Rock Ventures, with three of the hottest market debuts coming straight from the fund's portfolio. That success is no coincidence, the group says, and its founders gave Nature an inside look at its painstaking process of choosing which companies to bankroll and which to let slide.
Canaan Partners and 5AM Ventures are launching a new Yale spinout focused on a new approach to shutting down proteins.
San Diego police say that biotech entrepreneur Hans Petersen shot and wounded his brother-in-law Ron Fletcher and the University of California, San Diego scientist Steven Dowdy at separate times and locations Thursday, The Associated Press reported.